Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureZenji Makita, Jonathan Winston, Allen Kaufman et al.|The Lancet|1994Cited by 372
High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers.Toshiya Atsumi, Richard Bucala, Jason Chesney et al.|PubMed|2002Cited by 326
Involvement of β2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophagesYuko Hasunuma, Takayoshi Koike, T. Katahira et al.|Clinical & Experimental Immunology|1997Cited by 277
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195Kazuhisa Tsuchida, Takayoshi Koike, Hideaki Miyoshi et al.|Diabetologia|1999Cited by 214
Involvement of beta2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophagesYuko Hasunuma, Takayoshi Koike, Eiji Matsuura et al.|Clinical & Experimental Immunology|1997Cited by 211